HEALY JAMES
SEC Form 4 insider trading activity
HEALY JAMES has filed 3 SEC Form 4 filings (7 transaction rows) across 2 companies, including RAPP, SPTX, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Oct 30, 2026.
On the most recent filing, HEALY JAMES is listed as Director at Rapport Therapeutics, Inc. Inside the rolling window, HEALY JAMES reported 1 open-market purchase totaling $20.4M in RAPP and no open-market sales.
Companies traded
Other insiders at RAPP
Insider Buying
$20.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HEALY JAMES made?
HEALY JAMES has filed 3 SEC Form 4 filings (7 transaction rows) across 2 companies, including RAPP, SPTX since 2025.
Which companies does HEALY JAMES trade?
HEALY JAMES has filed SEC Form 4 disclosures for 2 companies, including RAPP, SPTX.
When was HEALY JAMES's most recent SEC Form 4 filing?
HEALY JAMES's most recent SEC Form 4 filing on Tracefour is dated Oct 30, 2026.
What is HEALY JAMES's total buy and sell value in the current window?
Inside the rolling retention window, HEALY JAMES bought $20.4M and sold $0 based on SEC Form 4 filings.
What was HEALY JAMES's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 969,480 RAPP shares on 2026-10-28, worth $20.4M, per SEC Form 4 filings.